{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:53:10Z","timestamp":1790632390029,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.clnu.2019.12.024","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T19:55:42Z","timestamp":1577390142000},"page":"2889-2895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Comparison of the prognostic value of ECOG-PS, mGPS and BMI\/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5272-5906","authenticated-orcid":false,"given":"Ross D.","family":"Dolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Daly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei M.J.","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9214-0091","authenticated-orcid":false,"given":"Marie","family":"Fallon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4330-9705","authenticated-orcid":false,"given":"Aoife","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald C.","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry J.","family":"Laird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2019.12.024_bib1","first-page":"79","article-title":"Loss of muscle mass in the end of life in patients with advanced cancer","volume":"23","author":"Wallengren","year":"2015","journal-title":"Support Care Cancer : J Multinatl Assoc Support Care Cancer"},{"key":"10.1016\/j.clnu.2019.12.024_bib2","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1200\/JCO.2015.65.7742","article-title":"Quality of life in patients with advanced cancer: differential association with performance status and systemic inflammatory response","volume":"34","author":"Laird","year":"2016","journal-title":"J\u00a0Clin Oncol : Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.clnu.2019.12.024_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.critrevonc.2017.06.002","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with advanced inoperable cancer: systematic review and meta-analysis","volume":"116","author":"Dolan","year":"2017","journal-title":"Crit Rev Oncol Hematol"},{"issue":"9","key":"10.1016\/j.clnu.2019.12.024_bib4","doi-asserted-by":"crossref","first-page":"e960","DOI":"10.1634\/theoncologist.2018-0474","article-title":"\u201cHow long have I got?\u201d-A prospective cohort study comparing validated prognostic factors for use in patients with advanced cancer","volume":"24","author":"Simmons","year":"2019","journal-title":"The Oncologist"},{"key":"10.1016\/j.clnu.2019.12.024_bib5","doi-asserted-by":"crossref","first-page":"5456","DOI":"10.1158\/1078-0432.CCR-13-1066","article-title":"Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system","volume":"19","author":"Laird","year":"2013","journal-title":"Clin Cancer Res : Off J Am Assoc Cancer Res"},{"key":"10.1016\/j.clnu.2019.12.024_bib6","first-page":"188","article-title":"Diagnostic criteria for cancer cachexia: data versus dogma","volume":"19","author":"Martin","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnu.2019.12.024_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1200\/JCO.2014.56.1894","article-title":"Diagnostic criteria for the classification of cancer-associated weight loss","volume":"33","author":"Martin","year":"2015","journal-title":"J\u00a0Clin Oncol : Off J Am Soc Clin Oncol"},{"issue":"3","key":"10.1016\/j.clnu.2019.12.024_bib8","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.amjsurg.2017.08.044","article-title":"Staging the tumor and staging the host: a two centre, two country comparison of systemic inflammatory responses of patients undergoing resection of primary operable colorectal cancer","volume":"216","author":"Park","year":"2017","journal-title":"Am J Surg"},{"key":"10.1016\/j.clnu.2019.12.024_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bjc.2013.418","article-title":"Cancer and systemic inflammation: stage the tumour and stage the host","volume":"109","author":"McMillan","year":"2013","journal-title":"Br J Canc"},{"key":"10.1016\/j.clnu.2019.12.024_bib10","doi-asserted-by":"crossref","first-page":"e588","DOI":"10.1016\/S1470-2045(18)30415-7","article-title":"Integration of oncology and palliative care: a lancet oncology commission","volume":"19","author":"Kaasa","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnu.2019.12.024_bib11","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.pain.2010.10.035","article-title":"Cancer pain and its relationship to systemic inflammation: an exploratory study","volume":"152","author":"Laird","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.clnu.2019.12.024_bib12","first-page":"446","article-title":"The combination of weight loss grade, performance status, and Glasgow Prognostic Score contribute to survival discrimination in advanced cancer patients at risk for cachexia","author":"Martin","year":"2015"},{"key":"10.1016\/j.clnu.2019.12.024_bib13","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","article-title":"ESPEN expert group recommendations for action against cancer-related malnutrition","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr (Edinb)"},{"key":"10.1016\/j.clnu.2019.12.024_bib14","article-title":"The relationship between ECOG-PS\/mGPS, body composition, physical function and survival in patients with advanced cancer","author":"Dolan","year":"2018","journal-title":"Cancer Medicine"},{"key":"10.1016\/j.clnu.2019.12.024_bib15","doi-asserted-by":"crossref","first-page":"16717","DOI":"10.1038\/s41598-017-16955-5","article-title":"The role of the systemic inflammatory response in predicting outcomes in patients with operable cancer: systematic review and meta-analysis","volume":"7","author":"Dolan","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnu.2019.12.024_bib16","first-page":"220","article-title":"Terminology in cancer cachexia: importance and status","volume":"15","author":"MacDonald","year":"2012","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnu.2019.12.024_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12603-018-1142-1","article-title":"Editorial: screening for malnutrition (undernutrition) in primary care","volume":"23","author":"Morley","year":"2019","journal-title":"J\u00a0Nutr Health Aging"},{"key":"10.1016\/j.clnu.2019.12.024_bib18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ctrv.2013.11.007","article-title":"Towards a simple objective framework for the investigation and treatment of cancer cachexia: the Glasgow Prognostic Score","volume":"40","author":"Douglas","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.clnu.2019.12.024_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clnu.2016.07.015","article-title":"ESPEN guidelines on nutrition in cancer patients","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr (Edinb)"},{"key":"10.1016\/j.clnu.2019.12.024_bib20","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.1016\/S1470-2045(14)70263-3","article-title":"Cancer-related inflammation and treatment effectiveness","volume":"15","author":"Diakos","year":"2014","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clnu.2019.12.024_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bmjspcare-2017-001440","article-title":"Cancer cachexia: rationale for the MENAC (Multimodal-Exercise, nutrition and anti-inflammatory medication for cachexia) trial","volume":"8","author":"Solheim","year":"2018","journal-title":"BMJ Support Palliat Care"},{"issue":"4","key":"10.1016\/j.clnu.2019.12.024_bib22","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/SPC.0000000000000398","article-title":"Targeting IL-1 alpha in cancer cachexia: a narrative review","volume":"12","author":"McDonald","year":"2018","journal-title":"Curr Opin Support Palliat Care"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561419332121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561419332121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:55:46Z","timestamp":1759366546000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561419332121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0261561419332121"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2019.12.024","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of the prognostic value of ECOG-PS, mGPS and BMI\/WL: Implications for a clinically important framework in the assessment and treatment of advanced cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2019.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}